Resource Logo
CDC HIV/AIDS/Viral Hepatitis/STD/TB Prevention News Update

UNITED STATES: US to Partner with Big Pharma for Drug Discovery




 

Reuters (05.03.12) - Wednesday, May 09, 2012

The National Institutes of Health (NIH) announced Thursday it is partnering with Pfizer Inc., AstraZeneca Plc., and Eli Lilly and Co. to find new uses for 24 existing drug compounds.

All the compounds have been shown to be safe, but they were shelved for being ineffective against the diseases they were developed to treat. Drugmakers typically spend $2 billion and 14 years bringing medicines to market. In the past, dozens of drugs that were originally developed for one disease have been repurposed for another - usually by chance. For example, AZT (azidothymidine) was approved in the 1960s to treat cancer but abandoned for lack of efficacy. It later became the first effective treatment for HIV.

NIH will spend $20 million annually for researchers to find new uses for the 24 compounds. "We need to speed the pace at which we are turning discoveries into better health outcomes," said Dr. Francis Collins, the agency's director. "The idea here is not to depend on serendipity." Scientists who discover a new use for a compound will be eligible for royalty payments if the drug reaches the market, while the pharmaceutical firm will hold the patent rights. The names of the 24 compounds in the pilot project will be disclosed next month, NIH said.

"NIH looks forward to working with our partners in industry and academia to tackle an urgent need that is beyond the scope of any one organization or sector," Collins said.



 


Copyright © 2012 -CDC Prevention News Update, Publisher. All rights reserved to Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.



Information in this article was accurate in May 9, 2012. The state of the art may have changed since the publication date. This material is designed to support, not replace, the relationship that exists between you and your doctor. Always discuss treatment options with a doctor who specializes in treating HIV.